# Retrobulbar Methylprednisolone as Adjunctive Treatment in Optic Neuritis Trial

> **NCT04942002** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Asociación para Evitar la Ceguera en México** · enrollment: 50 (estimated)

## Conditions studied

- Optic Neuritis
- Treatment
- Methylprednisolone

## Interventions

- **DRUG:** Methylprednisolone Acetate 40 MG/ML [Depo-Medrol]
- **DRUG:** Placebo Comparator: Standard treatment + placebo

## Key facts

- **NCT ID:** NCT04942002
- **Lead sponsor:** Asociación para Evitar la Ceguera en México
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-15
- **Primary completion:** 2023-06-15
- **Final completion:** 2023-09-15
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04942002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04942002, "Retrobulbar Methylprednisolone as Adjunctive Treatment in Optic Neuritis Trial". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04942002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*